Conversely, there was an apparent rise of the percentage of TUNEL-positive tumor cells and a significant decline of Ki67-positive tumor cells in MSCs-Sirt1 treatment groups (Fig. 2D–F). This evidence concerns the gene MKI67 and neoplasm.